Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
Ahead of Q3 results, lululemon faces U.S. softness and tariff pressure while international strength and long-term initiatives support its outlook.
Here’s a look back at what happened in the Chicago area on Dec. 5, according to the Tribune’s archives. Is an important event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback